SPECTRA: A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19 (clinicaltrials.gov) - Jun 29, 2023 - P2/3 | N=31454 | Completed | Sponsor: Clover Biopharmaceuticals AUS Pty Ltd | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
|